Axogen, Inc. — Director's Dealing 2023

Oct 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2023-07-18

Reporting Person: DeVinney Erick Wayne (VP Peripheral Nerve Science)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-18	Common Stock	A	1579	—	Acquired	114241	Direct
2023-10-13	Common Stock	D	864	$4.04	Disposed	113377	Direct

Footnotes

F1: This reflects the number of shares issued upon the attainment of certain performance criteria.

F2: This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent an open market sale.